pure scientific

PURE SCIENTIFIC
TECHNOLOGIES INC.

Developing new patent-pending drug delivery systems

PURE SCIENTIFIC
TECHNOLOGIES INC.

DEVELOPING NEW PATENT-PENDING
DRUG DELIVERY SYSTEM

PURE SCIENTIFIC
TECHNOLOGIES INC.

DEVELOPING NEW PATENT-PENDING
DRUG DELIVERY SYSTEM

pure scientificpure scientific

OUR MISSION

To develop and market innovative
products based on its technologies
utilizing Heliox and other gases
for delivery of pharmaceuticals
and CBD directly into the lungs.

OUR MISSION

To develop and market innovative
products based on its patent-pending
technologies utilizing Heliox and
other gases for needle-free delivery
of pharmaceuticals and CBD
directly into the lungs.

OUR MISSION

To develop and market innovative
products based on its patent-pending
technologies utilizing Heliox and
other gases for needle-free delivery
of pharmaceuticals and CBD
directly into the lungs.

PST HELIOX INHALERPST HELIOX INHALER

“striving to make medicine work better for you….”

Leveraging Helox as a Carrier Gas, our aim is to
maximize benefits of drugs used to treat
diseases such as lung cancer, chronic bronchitis,
asthma and other obstructive pulmonary
conditions.

PST HELIOX INHALER

“striving to make medicine
work better for you….”

Leveraging Helox as a Carrier Gas,
our aim is to maximize benefits of drugs
used to treat diseases such as lung cancer,
chronic bronchitis, asthma and other
obstructive pulmonary conditions.

PST HELIOX INHALER

“striving to make medicine
work better for you….”

Leveraging Helox as a Carrier Gas,
our aim is to maximize benefits of drugs
used to treat diseases such as lung cancer,
chronic bronchitis, asthma and other
obstructive pulmonary conditions.

Growing Market

The CBD industry is flourishing, conservatively projected to hit $16 billion in the U.S. by 2025. Reported by Forbes

20+ Years Experience

Our team of executives has the experience and commitment that it takes to bring medical products to market.

More Effective Delivery

This new delivery system offers the opportunity for a user-friendly inhaler.

MISSION

To develop and market innovative products based on its patent-pending technologies utilizing Heliox and other gases for delivery of pharmaceuticals and CBD directly into the lungs.

TECHNOLOGY UTILIZING HELIOX

TECHNOLOGY UTILIZING HELIOX

The use of Heliox as a primary carrier gas offers the opportunity for a more efficient and more comfortable respiratory treatment experience.

Our devices are being developed to offer improvements (enhancements) over conventional inhalers and nebulizers and are designed to effectuate the rapid and measured delivery of the desired pharmaceutical directly into the lungs utilizing a mixture of helium and oxygen (”Heliox”) to carry the chemically active pharmaceutical directly into the bloodstream to treat lung disease and other pulmonary conditions. Heliox is commercially available and has been safely used for years for medical applications.

Pure Scientific Technologies intends to expand the use of Heliox beyond the current limited medical use to treat a wide variety of conditions.

BENEFITS OF HELIOX

  • FDA-approved breathing gas, non-toxic, non-carcinogenic with a history of decades of critical care use.
  • Comprised with Helium (He) and Oxygen (O₂) typically in a ratio of 80:20 or 70:30
  • Small helium atom makes Heliox less dense than pure oxygen and more easily absorbed by the lungs
  • An example: During acute asthma exacerbations, albuterol nebulized with Heliox (Left) leads to more significant improvement in spirometry compared with albuterol nebulized with oxygen (Right) because the lower-density Heliox improves albuterol deposition in the distal airways.

NEWS FROM PURE SCIENTIFIC TECHNOLOGIES

Pure Scientific Featured in MedTech Top Ten Startups

Pure Scientific Technologies was featured in MedTech Outlook’s article on MedTech Top Ten Startups. To read the whole story check out this link: Med Tech Article

HELIOS: PST HELIOX INHALER

1
2
3
4
HELIOS: PST HELIOX INHALER

PST Heliox Inhaler smart technology may be integrated with a patient’s smartphone app via Bluetooth that provides data collection on dosage data, flow measurement, pressure, date, and time. The system is designed to provide secure data and metrics for patients, caregivers, and physicians leading to potentially better outcomes than traditional solutions.

In addition to that, the PST HELIOX INHALER utilizes a closed loop system with digital dosing controls that coordinate delivery of the active ingredient pharmaceutical/CBD compound and Heliox from a small cartridge in short measured doses with the peak of inspiration.

INCREDIBLE MARKET OPPORTUNITY

25,000,000

CDC reports 2018 Asthma incidents

11,000,000

Reported cases having at least 1 asthma attack annually

228,150

American Cancer Society 2019 lung cancer incidents

133,965

CDC reports 2019 COPD (emphysema, chronic bronchitis)

EXPERIENCED MANAGEMENT TEAM

L. Michael Cutrer is a highly accomplished executive with extensive management and technical experience in the medical device field.

L Michael Cutrer

Irwin Olian is a highly successful entrepreneur with a strong legal and finance background. He is a creative innovator and proven business leader.

Over the past thirty years, he has leveraged his skills in strategic business planning, management, administration, finance, and law with creative thought and innovation to provide leadership to a large number of emerging companies.

Irwin A. Olian

Henry has over 20 years’ experience in financial and accounting matters for private and public companies, including familiarity with both Canadian and U.S. accounting standards.

Dr. Baldauf uses highly developed technologies such as Nitric Oxide and Heliox in the treatment of critically ill patients. She has extensive experience in the areas of mechanical ventilation and advanced airway management.

Mary Baldauf, M.D.

Dr. Martin Urban is a highly experienced radiologist with extensive management and entrepreneurial skills, whose 30-year career covers the full range of interventional radiology, computed tomography and ultrasound.

Dr. Martin Urban

Philip Cacayorin, serving as Vice President – Technology, brings his exceptional advanced mathematics, physics and computer engineering skills to bear on development, fabrication and marketing of our new line of products utilizing the Company’s patent pending infusion technologies employing Heliox and helium as integral components of delivery systems for CBD and various pharmaceuticals directly into the lungs.

Philip Cacayorin

Lee has thirty-three years experience in sales and marketing, IT, management and business development with a strong investor relations background. His professional approach and focus will be communicating the PST story to the investment industry.

Lee Dunston

Citation – CBD Market Could Pull in $16 Billion by 2025, Says Study –This figure was far higher than what the Cowen analysts had expected. March 12, 2019. Forbes